Validations: Change Control, Verification vs Re-Validation

Stability/Hold-Time Bridges: When to Add Pulls

Stability/Hold-Time Bridges: When to Add Pulls Understanding Stability and Hold-Time Bridges In the realm of pharmaceutical development, the concepts of stability and hold-time bridges play a crucial role in ensuring product safety and efficacy. Stability studies assess how drugs behave under various environmental conditions over time, while hold-time studies determine the appropriate timeframes for drug components to remain in specific…

Continue Reading Stability/Hold-Time Bridges: When to Add Pulls

Stability/Hold-Time Bridges: When to Add Pulls

Stability/Hold-Time Bridges: When to Add Pulls In the ever-evolving landscape of pharmaceutical development and manufacturing, adhering to regulatory standards is paramount. Success hinges not only on the efficacy of products but also on rigorous compliance with Good Manufacturing Practices (cGMP). This article focuses on the critical concept of stability and hold-time bridges, specifically addressing the nuances of when to implement…

Continue Reading Stability/Hold-Time Bridges: When to Add Pulls

Re-Establishing AQL/Cpk: How Much Evidence Is Enough

Re-Establishing AQL/Cpk: How Much Evidence Is Enough The pharmaceutical industry operates in a heavily regulated environment, necessitating robust validation processes to ensure product quality, efficacy, and safety. Among the critical facets of validation are change control and the subsequent assessments of the quality characteristics of products, notably Acceptable Quality Level (AQL) and Process Capability Index (Cpk). The objective of this…

Continue Reading Re-Establishing AQL/Cpk: How Much Evidence Is Enough

Batch Definition & Lot Structure Impacts on Sampling

Batch Definition & Lot Structure Impacts on Sampling Batch Definition & Lot Structure Impacts on Sampling Understanding Batch Definitions and Lot Structures In the pharmaceutical industry, batch definitions and lot structures are crucial for maintaining compliance with regulatory standards while ensuring product quality and safety. A correct understanding of these concepts underpins several key activities, including sampling plans and change…

Continue Reading Batch Definition & Lot Structure Impacts on Sampling

Batch Definition & Lot Structure Impacts on Sampling

Batch Definition & Lot Structure Impacts on Sampling Batch Definition & Lot Structure Impacts on Sampling Introduction to Batch Definition and Lot Structure In the pharmaceutical industry, the concepts of batch definition and lot structure play a critical role in ensuring compliance with regulatory requirements, maintaining product quality, and implementing effective sampling plans. A clear understanding of these terms and…

Continue Reading Batch Definition & Lot Structure Impacts on Sampling

Sampling Location/Time Matrix for Post-Change Checks

Sampling Location/Time Matrix for Post-Change Checks Sampling Location/Time Matrix for Post-Change Checks Understanding Change Control Impact Assessment Change control is a critical component of pharmaceutical manufacturing and quality assurance. It ensures that any modifications in processes, equipment, or formulations are systematically evaluated for their potential impact on product quality and patient safety. The change control impact assessment begins with the…

Continue Reading Sampling Location/Time Matrix for Post-Change Checks

Sampling Location/Time Matrix for Post-Change Checks

Sampling Location/Time Matrix for Post-Change Checks Introduction In the highly regulated pharmaceutical industry, maintaining compliance with guidelines from organizations such as the US FDA, EMA, and MHRA is paramount, especially when dealing with change control processes. This is particularly true for post-change checks, where a structured approach to the sampling location and time matrix plays a crucial role in ensuring…

Continue Reading Sampling Location/Time Matrix for Post-Change Checks

DoE as a Bridge: Using Prior Knowledge for Faster Close

DoE as a Bridge: Using Prior Knowledge for Faster Close Understanding Change Control Impact Assessment In the pharmaceutical industry, change control is a critical mechanism to manage modifications that could affect product quality, compliance, or safety. A change control impact assessment identifies the possible repercussions of a change and establishes a framework for managing that change in accordance with regulatory…

Continue Reading DoE as a Bridge: Using Prior Knowledge for Faster Close

DoE as a Bridge: Using Prior Knowledge for Faster Close

DoE as a Bridge: Using Prior Knowledge for Faster Close The pharmaceutical industry continually faces the need to implement efficient change control processes to ensure regulatory compliance while maintaining product quality. This necessitates a thorough understanding of the difference between verification and re-validation, as well as the role that Design of Experiments (DoE) can play as a bridge in change…

Continue Reading DoE as a Bridge: Using Prior Knowledge for Faster Close

Power and Confidence for Post-Change Decisions

Power and Confidence for Post-Change Decisions Power and Confidence for Post-Change Decisions In the pharmaceutical industry, maintaining compliance while effectively managing change is crucial. Regulatory authorities such as the FDA, EMA, and MHRA have established stringent guidelines for change control processes. This tutorial serves as a comprehensive guide for professionals in quality assurance, clinical operations, regulatory affairs, and medical affairs,…

Continue Reading Power and Confidence for Post-Change Decisions